Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

How I approach the prevention and treatment of thrombotic complications in hospitalized patients

Imo J. Akpan, Beverley J. Hunt

Blood (2023) 142 (9): 769–776.

https://doi.org/10.1182/blood.2021014835

Published: 2023

Journal Articles

Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients

Katherine J. Creeper, Katie White, Karen Breen, Beverley J. Hunt

Blood (2022) 140 (Supplement 1): 11342–11343.

https://doi.org/10.1182/blood-2022-155899

Published: 2022

Journal Articles

Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis

Brian Craven, William Lester, Sara Boyce, Will Thomas, Angela Kanny, Claire Davies, Sue Pavord, Joannes Hermans, Michael Makris, Emily Bart-Smith, Sarah Arnott, Beverley J. Hunt, Pavel Chudakou, Anthony Calvert, Deepak Singh, Marie Scully

Blood (2022) 139 (16): 2553–2560.

https://doi.org/10.1182/blood.2021014684

Published: 2022

Includes: Supplemental data

Journal Articles

Outcomes of Patients Receiving Direct Oral Anticoagulants for Myeloproliferative Neoplasm Associated Venous Thromboembolism

Andrew Doyle, MBBS, BSc, FRPATH, Karen Breen, MD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Deepti Radia, Beverley J. Hunt, Gavin Ling, MBBS, BSc, FRCPath, Claire N Harrison, Professor, Natalia Curto Garcia, MD MBBS

Blood (2019) 134 (Supplement_1): 4183.

https://doi.org/10.1182/blood-2019-128170

Published: 2019

Journal Articles

Reversing anti–factor Xa agents and the unmet needs in trauma patients

Beverley J. Hunt, Matthew D. Neal, Jakob Stensballe

Blood (2018) 132 (23): 2441–2445.

https://doi.org/10.1182/blood-2018-06-850396

Published: 2018

Journal Articles

Early Outcomes Following Endoluminal Deep Venous Reconstruction Using Dedicated Venous Stents

Prakash Saha, BSc MBBS PhDMRCS, Stephen A Black, MDFRCS, Ander Cohen, Narayan Karunanithy, Beverley J Hunt, Karen Breen

Blood (2015) 126 (23): 4721.

https://doi.org/10.1182/blood.V126.23.4721.4721

Published: 2015

Journal Articles

Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism

Deepa Jayakody Arachchillage, Ian J Mackie, Maria Efthymiou, Andrew Chitolie, Beverley J Hunt, David Isenberg, Munther Khamashta, Samuel Machin, Hannah Cohen

Blood (2015) 126 (23): 2328.

https://doi.org/10.1182/blood.V126.23.2328.2328

Published: 2015

Journal Articles

Markers of Endothelial Angiogenic Dysfunction in Patients with Antiphospholipid Antibodies

Karen A Breen, MB, Kiran Parmar, MSc, Beverley J Hunt, FRCP, FRCPath, MD

Blood (2011) 118 (21): 2300.

https://doi.org/10.1182/blood.V118.21.2300.2300

Published: 2011

Journal Articles

Outcome of Kidney Transplantation in Patients with Antiphospholipid Antibodies: A Case Series

Karen A Breen, MB, Kaji Sritharan, Jonathon Olsburgh, Beverley J Hunt, FRCP, FRCPath, MD

Blood (2011) 118 (21): 1230.

https://doi.org/10.1182/blood.V118.21.1230.1230

Published: 2011

Journal Articles

Circulating Microparticles and Microparticle Procoagulant Activity in Patients with Antiphospholipid Antibodies

Karen A Breen, MB, Katy Sanchez, Nicola Kirkman, Kiran Parmar, MSc, Beverley J Hunt, FRCP, FRCPath, MD

Blood (2011) 118 (21): 5244.

https://doi.org/10.1182/blood.V118.21.5244.5244

Published: 2011

Journal Articles

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

Marie Scully, Vickie McDonald, Jamie Cavenagh, Beverley J. Hunt, Ian Longair, Hannah Cohen, Samuel J. Machin

Blood (2011) 118 (7): 1746–1753.

https://doi.org/10.1182/blood-2011-03-341131

Published: 2011

Includes: Supplemental data

Journal Articles

First-trimester low-dose prednisolone in refractory antiphospholipid antibody–related pregnancy loss

Kate Bramham, Mari Thomas, Catherine Nelson-Piercy, Munther Khamashta, Beverley J. Hunt

Blood (2011) 117 (25): 6948–6951.

https://doi.org/10.1182/blood-2011-02-339234

Published: 2011

Journal Articles

The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Beverley J Hunt, MD

Blood (2010) 116 (21): 3179.

https://doi.org/10.1182/blood.V116.21.3179.3179

Published: 2010

Journal Articles

Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Kiran Parmar, MSc, Beverley J Hunt, MD

Blood (2010) 116 (21): 4216.

https://doi.org/10.1182/blood.V116.21.4216.4216

Published: 2010

Journal Articles

A novel antiphospholipid antibody agent?

Beverley J. Hunt

Blood (2010) 115 (11): 2124–2125.

https://doi.org/10.1182/blood-2009-12-258889

Published: 2010

Journal Articles

International consensus report on the investigation and management of primary immune thrombocytopenia

Blood (2010) 115 (2): 168–186.

https://doi.org/10.1182/blood-2009-06-225565

Published: 2010

Includes: Supplemental data

Journal Articles

Resistance to Annexin A5 Anticoagulant Activity and Specificity for Anti-B2GPI Domain I Antibodies in Obstetric Antiphospholipid Syndrome

Beverley J Hunt, FRCP, FRCPath, MD, Xiao-Xuan Wu, MD, Bas de Laat, Alan A Arslan, MD, Kiran Parmar, MSc, Sarah Stuart-Smith, MD, Jacob H Rand, MD

Blood (2008) 112 (11): 3821.

https://doi.org/10.1182/blood.V112.11.3821.3821

Published: 2008

Journal Articles

Peripartum Haemostatic Changes in Women in Labour

Eleftheria Lefkou, MD, PhD, Kiran Parmar, FIBMS, MSc, Apostolos Mamopoulos, MD, PhD, Sevasti Masouridou, MD, PhD, Vassilios Karagiannis, MD, PhD, Beverley J Hunt, FRCP, FRCPath, MD

Blood (2008) 112 (11): 5475.

https://doi.org/10.1182/blood.V112.11.5475.5475

Published: 2008

Journal Articles

Impact of Platelet Glycoprotein Polymorphisms upon Clinical Events in Essential Thrombocythaemia Patients Enrolled in the PT1 Trial.

Susan E. Robinson, MSc, MRCPath, Peter J. Campbell, FRCPA, PhD, Georgina Buck, MSc, Keith Wheatley, DPhil, Jacqueline A. Cutler, BSc, Ruth B. Wheeler, BSc, PhD, Savita Rangarajan, FRCP, FRCPath, Beverley J. Hunt, RCPath, Anthony R. Green, FRCPath, FMedSci, Claire N. Harrison, MD, FRCPath

Blood (2007) 110 (11): 2543.

https://doi.org/10.1182/blood.V110.11.2543.2543

Published: 2007

Journal Articles

Myeloproliferative Disorders Are Associated with an Increase in Levels of Prothrombotic and Inflammatory Markers Despite Cytoreductive Therapy.

Betty Y.Y. Cheung, MRCP, MRCPath, Beverley J. Hunt, MD FRCPath, Kiran Parmar, MSc, Yvonne Daniel, MSc, Deepti Radia, MRCP MRCPath, Claire N. Harrison, MD MRCPath

Blood (2006) 108 (11): 3625.

https://doi.org/10.1182/blood.V108.11.3625.3625

Published: 2006

NARROW

How I approach the prevention and treatment of thrombotic complications in hospitalized patients

Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients

Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis

Outcomes of Patients Receiving Direct Oral Anticoagulants for Myeloproliferative Neoplasm Associated Venous Thromboembolism

Reversing anti–factor Xa agents and the unmet needs in trauma patients

Early Outcomes Following Endoluminal Deep Venous Reconstruction Using Dedicated Venous Stents

Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism

Markers of Endothelial Angiogenic Dysfunction in Patients with Antiphospholipid Antibodies

Outcome of Kidney Transplantation in Patients with Antiphospholipid Antibodies: A Case Series

Circulating Microparticles and Microparticle Procoagulant Activity in Patients with Antiphospholipid Antibodies

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

First-trimester low-dose prednisolone in refractory antiphospholipid antibody–related pregnancy loss

The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

A novel antiphospholipid antibody agent?

International consensus report on the investigation and management of primary immune thrombocytopenia

Resistance to Annexin A5 Anticoagulant Activity and Specificity for Anti-B2GPI Domain I Antibodies in Obstetric Antiphospholipid Syndrome

Peripartum Haemostatic Changes in Women in Labour

Impact of Platelet Glycoprotein Polymorphisms upon Clinical Events in Essential Thrombocythaemia Patients Enrolled in the PT1 Trial.

Myeloproliferative Disorders Are Associated with an Increase in Levels of Prothrombotic and Inflammatory Markers Despite Cytoreductive Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only